Abstract:After the COVID-19 pandemic, messenger RNA (mRNA) has revolutionized traditional vaccine manufacturing. With the increasing number of RNA-based therapeutics, valuable new scientific insights into these molecules have emerged. One fascinating area of study is the formation of double-stranded RNA (dsRNA) during in vitro transcription (IVT) which is considered a significant impurity, as it has been identified as a major trigger in the cellular immune response pathway. Therefore, there is a growing importance placed to develop and optimize purification processes for the removal of this by-product. Traditionally, efforts have primarily focused on mRNA purification after IVT through chromatographic separations, with anion exchange and reverse phase chromatography emerging as effective tools for this purpose. However, to the best of our knowledge, the influence and significance of the quality of the linearized plasmid have not been thoroughly investigated. Plasmids production involves the growth of bacterial cultures, bacterial harvesting and lysis, and multiple filtration steps for plasmid DNA purification. The inherent complexity of these molecules, along with the multitude of purification steps involved in their processing, including the subsequent linearization and the less-developed purification techniques for linearized plasmids, often result in inconsistent batches with limited control over by-products such as dsRNA. This study aims to demonstrate how the purification process employed for linearized plasmids can impact the formation of dsRNA. Several techniques for the purification of linearized plasmids based on both, resin filtration and chromatographic separations, have been studied. As a result of that, we have optimized a chromatographic method for purifying linearized plasmids using monolithic columns with C4 chemistry (butyl chains located in the surface of the particles), which has proven successful for mRNAs of various sizes. This chromatographic separation facilitates the generation of homogeneous linearized plasmids, leading to mRNA batches with lower levels of dsRNA during subsequent IVT processes. This finding reveals that dsRNA formation is influenced not only by RNA polymerase and IVT conditions but also by the quality of the linearized template. The results suggest that plasmid impurities may contribute to the production of dsRNA by providing additional templates that can be transcribed into sequences that anneal with the mRNA molecules. This highlights the importance of considering the quality of plasmid purification in relation to dsRNA generation during transcription. Further investigation is needed to fully understand the mechanisms and implications of plasmid-derived dsRNA. This discovery could shift the focus in mRNA vaccine production, placing more emphasis on the purification of linearized plasmids and potentially saving, in some instances, a purification step for mRNA following IVT.

Enzymatic Isolation and Microfluidic Electrophoresis Analysis of Residual dsRNA Impurities in mRNA Vaccines and Therapeutics

Comprehensive Impurity Profiling of mRNA: Evaluating Current Technologies and Advanced Analytical Techniques

Development and Application of Automated Sandwich ELISA for Quantitating Residual dsRNA in mRNA Vaccines

Messenger RNA chromatographic purification: advances and challenges

Evaluation of size-exclusion chromatography, multi-angle light scattering detection and mass photometry for the characterization of mRNA

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development

Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced

Abstract 3254: Development of novel luminescent assays for sensitive and specific quantitation of double-stranded RNA in mRNA vaccines

Enabling functionality and translation fidelity characterization of mRNA-based vaccines with a platform-based, antibody-free mass spectrometry detection approach

Rapid and scalable detection of synthetic mRNA byproducts using polynucleotide phosphorylase and polythymidine oligonucleotides

Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance

Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction

A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems

Importance of RNase monitoring during large-scale manufacturing and analysis of mRNA-LNP based vaccines

High Recovery Chromatographic Purification of mRNA at Room Temperature and Neutral pH

Purifying circular RNA by ultrafiltration

Development of Biolayer Interferometry (BLI)-Based Double-Stranded RNA Detection Method with Application in mRNA-Based Therapeutics and Vaccines

Determination of linearized pDNA template in mRNA production process using HPLC

Effective Synthesis of High-Integrity mRNA Using In Vitro Transcription

Removal of Double-Stranded RNA Contaminants During Template-Directed Synthesis of mRNA

Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses